CuraScientific Corp. is a bioscience company, which engages in the manufacture of commercial chemical products with applications in commercial sterilization for agriculture, warehousing, hospitality, and medical facilities. The company is headquartered in Nevada City, California. The company went IPO on 2001-10-16. The company has developed an effective germ fighter, DiOx+, a disinfectant sterilizer that kills 99.99% of harmful pathogens without dangerous toxic exposure to the user or the environment. Its DiOx+ is an activated chlorine dioxide (Cl02) broad spectrum disinfectant that kills dangerous pathogens with no residual toxicity. The company protects the environment and human health from viruses, bacteria and harmful by-products left by other cleaning sanitizers, without a harsh smell or skin irritation. DiOx+ helps protect agricultural crops from disease and other pathogens like mold and fungus. The company is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers, and ecommerce support facilities.
Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Ingresos
7
0
0
0
Crecimiento de los Ingresos (YoY)
--
--
--
--
Costo de los ingresos
1
--
--
--
Utilidad bruta
5
--
--
--
Venta, General y Administración
20
7
4
4
Investigación y Desarrollo
2
3
4
9
Gastos de Operación
22
11
9
13
Otras Ingresos (Gastos) No Operativos
0
0
0
--
Ingreso antes de impuestos
-19
-14
-13
-12
Gasto por Impuesto a la Renta
--
--
--
--
Ingreso Neto
-19
-14
-13
-12
Crecimiento de la Utilidad Neta
--
8%
8%
--
Acciones en Circulación (Diluidas)
16.14
7.24
3.58
2.71
Cambio de Acciones (YoY)
--
102%
32%
--
EPS (Diluido)
-1.2
-2.01
-3.83
-4.45
Crecimiento de EPS
--
-47%
-14%
--
Flujo de efectivo libre
-15
-7
-8
-9
Flujo de efectivo libre por acción
--
--
--
--
Margen bruto
71.42%
--
--
--
Margen de operación
-242.85%
0%
0%
0%
Margen de beneficio
-271.42%
0%
0%
0%
Margen de flujo de caja libre
-214.28%
0%
0%
0%
EBITDA
-17
-11
-9
-13
Margen de EBITDA
-242.85%
0%
0%
0%
D&A para EBITDA
0
0
0
0
EBIT
-17
-11
-9
-13
Margen de EBIT
-242.85%
0%
0%
0%
Tasa de Impuesto Efectiva
--
--
--
--
Follow-Up Questions
Curascientific Corp'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, Alpha Cognition Inc'in toplam varlıkları $50 olup, net pérdida $-14'dir.
CSTF'ün temel finansal oranları nelerdir?
Alpha Cognition Inc'in cari oranı 5.55, net kâr marjı 0, hisse başına satış $0'dir.
Curascientific Corp'in geliri segment veya coğrafya bazında nasıl dağılıyor?
El segmento de ingresos más grande es Alpha Cognition Inc, con unos ingresos de Quaint Oak Bank en el último informe de ganancias. En cuanto a la geografía, United States es el mercado principal para Alpha Cognition Inc, con unos ingresos de 33,494,999.
Curascientific Corp kârlı mı?
no, son mali tablolara göre Alpha Cognition Inc'in net pérdida $-14'dir.
Curascientific Corp'in herhangi bir yükümlülüğü var mı?
sí, Alpha Cognition Inc'in yükümlülüğü 9'dir.
Curascientific Corp'in tedavüldeki hisse sayısı kaçtır?
Alpha Cognition Inc'in toplam tedavüldeki hisse sayısı 16.01'dir.